BRIEF-Glaxosmithkline says ‍Hal Barron appointed as chief scientific officer and president, research and development​

Spread the love

Nov 8 (Reuters) – Glaxosmithkline Plc

* ‍HAL BARRON HAS BEEN APPOINTED CHIEF SCIENTIFIC OFFICER AND PRESIDENT, RESEARCH AND DEVELOPMENT​

* ‍BARRON IS CURRENTLY PRESIDENT RESEARCH AND DEVELOPMENT AT CALICO​

* ‍BARRON WILL ASSUME HIS NEW ROLE AND JOIN BOARD ON 1 JANUARY 2018​ Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

Our Standards:The Thomson Reuters Trust Principles.